Purchase Order HHSN275201600650P

This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Imquest Biosciences, Inc. for $72,000.00. The order was not set aside for any specific business category. The ultimate completion date was September 30, 2017. Imquest Biosciences, Inc. is a preclinical contract research and development organization that provides services to evaluate the potential of new...

Microgenics Corporation, a clinical diagnostics subsidiary of Thermo Electron Corporation, was awarded a $225,000 firm fixed-price purchase order by the Court Services and Offender Supervision Agency (CSOSA) Pretrial Services Agency on May 12, 2020. The contract, which utilizes no set-aside designation, calls for the delivery of phencyclidine (PCP) immunoassay reagents, calibrators, and quality control materials, with performance to be completed in Washington, DC by May 11, 2025. Immunoassay...

Qiagen, LLC, a subsidiary of Qiagen N.V., was awarded a Blanket Purchase Agreement (BPA) call valued at $19,699.20 for drugs and biologicals on November 13, 2015, with an ultimate completion date of April 30, 2016. This contract, executed without a set-aside designation, reflects Qiagen's ability to compete effectively in the open federal marketplace. The work will be performed in Valencia, California. Qiagen, headquartered in Germantown, Maryland, is a foreign-owned, for-profit manufacturer...

Qiagen, LLC, a foreign-owned biotechnology manufacturer headquartered in Germantown, Maryland, was awarded a Blanket Purchase Agreement (BPA) call for in vitro products valued at $12,022.20 on October 19, 2017. This firm fixed price contract, issued by the Office of Logistics and Acquisition Operations, is scheduled for completion by April 30, 2018, with performance taking place in Germantown, Maryland. The award was made without a set-aside designation, indicating that Qiagen competed in the...

Qiagen, LLC received a $21,939.84 firm fixed-price Blanket Purchase Agreement (BPA) call for drugs and biologicals on January 11, 2016, with an ultimate completion date of April 30, 2016. The contract was awarded by a civilian federal agency without a set-aside designation, and performance is located in Valencia, California. As a child entity of Qiagen N.V., a multinational biotechnology company headquartered in the Netherlands, Qiagen, LLC specializes in molecular diagnostics, scientific...

Qiagen, LLC received a contract award valued at $15,686.40 for drugs and biologicals from a civilian federal agency on December 2, 2015, with an ultimate completion date of April 30, 2016. This contract was issued as a Blanket Purchase Agreement (BPA) call under firm fixed pricing, with no set-aside designation. The work will be performed in Valencia, California. Qiagen, LLC is a subsidiary of Qiagen N.V., a Netherlands-headquartered multinational biotechnology company specializing in...

Qiagen, LLC received a $17,992.08 firm fixed price Blanket Purchase Agreement (BPA) call award from the Office of Logistics and Acquisition Operations, a civilian federal agency, for drugs and biologicals. The contract, awarded on June 9, 2016, with an ultimate completion date of April 30, 2017, will be performed in Valencia, California. This award carries no set-aside designation, reflecting Qiagen's ability to compete effectively in the open federal marketplace. As a child entity of Qiagen...

Qiagen, LLC received a Blanket Purchase Agreement (BPA) call award valued at $22,178.16 for drugs and biologicals from the Office of Logistics and Acquisition Operations, a civilian federal agency. The contract, awarded on November 23, 2016, with completion targeted for April 30, 2017, utilizes firm fixed price terms and carries no set-aside designation, reflecting the contractor's ability to compete in the open federal marketplace. Performance will occur at the company's Valencia, California...

Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation, has received a firm fixed price delivery order from the Department of the Navy Bureau of Medicine and Surgery for $15,618.24. The order is for DRI OXYCODONE 500ML with an expected completion date of August 2, 2023. Microgenics will fulfill the order from its location in Fremont, California, leveraging the resources of parent company Thermo Electron Corporation as needed. No set-aside designation or major...

Qiagen, LLC received a Blanket Purchase Agreement (BPA) call award valued at $7,953.28 from the Office of Logistics and Acquisition Operations, a civilian federal agency, on January 18, 2017. The contract was awarded on a firm fixed-price basis without a set-aside designation, with an ultimate completion date of January 25, 2017. Performance is located in Valencia, California. As a subsidiary of Qiagen N.V., a multinational biotechnology company headquartered in the Netherlands, Qiagen, LLC...